Clinical and epidemiological characteristics resistant hypertension in the practice of family doctor

S. V. Busel

Abstract


Busel S.V. Clinical and epidemiological characteristics resistant hypertension in the practice of family doctor. Journal of Education, Health and Sport. 2016;6(11):702-714. eISSN 2391-8306. DOI http://dx.doi.org/10.5281/zenodo.225448

http://ojs.ukw.edu.pl/index.php/johs/article/view/4122

 

 

 

 

The journal has had 7 points in Ministry of Science and Higher Education parametric evaluation. Part B item 755 (23.12.2015).

755 Journal of Education, Health and Sport eISSN 2391-8306 7

© The Author (s) 2016;

This article is published with open access at Licensee Open Journal Systems of Kazimierz Wielki University in Bydgoszcz, Poland

Open Access. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium,

provided the original author(s) and source are credited. This is an open access article licensed under the terms of the Creative Commons Attribution Non Commercial License

(http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted, non commercial use, distribution and reproduction in any medium, provided the work is properly cited.

This is an open access article licensed under the terms of the Creative Commons Attribution Non Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted, non commercial

use, distribution and reproduction in any medium, provided the work is properly cited.

The authors declare that there is no conflict of interests regarding the publication of this paper.

Received: 02.11.2016. Revised 22.11.2016. Accepted: 30.11.2016.

 

Clinical and epidemiological characteristics RESISTANT HYPERTENSION IN THE PRACTICE OF FAMILY DOCTOR

 

S. V. Busel

 

Odessa National Medical University

 

Summary

Arterial hypertension (AH) is one the most extensive cardio-vascular risk factors all over the world. According to present day statistics 31.5% of Ukrainian adult population have arterial blood pressure (ABP) higher norm. Resistant AH is aa widely spread clinical problem and its faced by both general practioners and specialists. The presence of non-controlled AH increases cardio-vascular risk, promotes early and significant damage of target organs and tissues. Thus, the studies of resistant AH directed to optimization of pseudo-resistant AH differentional diagnostics and resistant AH are of top urgency. The investigations done highlighted a lot of complaints, higher figures of ABP, decrease of quality of life, comorbid pathology was met more often. 

Key words: resistant hypertension, pseudo-resistant hypertension.


Keywords


resistant hypertension, pseudo-resistant hypertension

Full Text:

PDF

References


Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and European Society of Cardiology (ESC)/ G.Mancia, R.Fagard, K.Narkiewicz et al. // J. Hypertens.– 2013.– Vol. 31.– P. 1281–1357.

Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research/A.C. David, J. Daniel, T. Stephen // Hypertension. – 2008, Apr. – P. 1403–1419.

Pimenta E. Resistant Hypertension: Incidence, Prevalence, and Prognosis/ E.Pimenta, D. A. Calhoun// Circulation.- 2012.- №125(13).- Р.1594-96.

Worldwide prevalence of hypertension: a systematic review /Kearney P., Whelton M., Reynolds K., et al. //J. of Hypertens. -2004. -Vol.22. -P.11-19.

Hypertension prevalence and blood pressure levels in European countries, Canada and the United States/ Wolf-Maier K., Cooper R.S., Banegas J.R., et al. //JAMA. -2003. -Vol.289. -P.2363-2369.

Sіrenko Yu.M. Arterіalna gіpertenzіya ta suputnya patologіya.– Doneck_ Vidavec Zaslavskii O.Yu.- 2010.– 383 s.

Obertinska O.G. Klіnіchnі aspekti rezistentnoї arterіalnoї gіpertenzії/ O.G. Obertinska // Ukr. kard. jurn.– 2014.– № 4.– S. 30–36.

Obertinska O.G. Rezistentna arterіalna gіpertenzіya_ poshuk optimalnoї kombіnovanoї terapії./O.G. Obertinska//Ukraїnskii kardіologіchnii jurnal.-2015.- № 6.-S.113-123.

Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High lood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure / Chobanian A.V., Bakris G.L., Black H.R. et al // Hypertension.- 2003.- № 42.- Р.1206-1252.

Roberie D.R. What is the prevalence of resistant hypertension in the United States/ Roberie D.R., Elliott W.J.// Curr Opin Cardiol.- 2012.-№ 27(4).-Р. 386-91.

Rezistentnaya arterialnaya gipertenziya_ Epidemiologiya i faktori riska/ I.E. Deneka_ A.A. Svetankova_ A.V. Rodionov//Racionalnaya farmakoterapiya v kardiologiiyuyu.-2016.-№12-S.459-464.

Mathers C., Stevens G., Mascarenhas M. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva, Switzerland: World Health Organization; 2009.

Hajjar I. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000 / I.Hajjar, T.A. Kotchen // JAMA. – 2003. – V.290. – P. 199–206.

Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community/ Lloyd-Jones D.M., Evans J.C., Larson M.G. et al. // Hypertens. –2000. – V. 36. – P. 594 –599.

Farmakoepidemiologiya arterialnoi gipertonii v Rossii _po rezultatam farmakoepidemiologicheskogo issledovaniya PIFAGOR III/ Leonova M.V., Belousov Yu.B., Shteinberg L.L. i dr. // Ros. kardiol. jurn.– 2011.– № 2.–S. 9–17.

Oganov RG, Timofeev TN, Koltunov IE Epidemiology of arterial hypertension in Russia. The federal monitoring results of 2003-2010. Kardiovaskulyarnaya Terapiya i Profilaktika 2011; 10 (1): 9-13.

Livenceva M.M. Vidi refrakternosti k antigipertenzivnoi terapii i vozmojnie puti ee preodoleniya/ M.M.Livenceva, T.A.Nechesova //Mejdunarodnie obzori: klinicheskaya praktika i zdorovey.-2013.-№ 5.-S.88-99.

ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)// JAMA.– 2002.– Vol. 288.– P. 2981–2997.

Cushman W.C., Ford C.E., Cutler J.A. et al. for the ALLHAT Collaborative Research Group. Success and predictors of blood pressure control in diverse North American settings: the Antihypertensive and Lipid-Lowering and Treatment to Prevent Heart Attack Trial (ALLHAT) // J. Clin.Hypertens. – 2002. – V. 4. – P. 393–404.

Boytsov SA, Balanova JA, Shalnova SA. Arterial hypertension among people aged 25-64: prevalence, awareness, treatment and control. According to studies essay. Kardiovaskulyarnaya Terapiya i Profilaktika 2014; 14 (4): 4-14.

Gonzaga C.C. Resistant hypertension and hyperaldosteronism/ C.C. Gonzaga, D.A. Calhoun // Curr. Hyperten. Rep.– 2008.– Vol. 10 (6).– P. 496–503.

Sequential nephron blockade vs. sequential renin-angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint study/ Bobrie G., Frank M., Azizi M. et al. // J. Hypertens.– 2012.– Vol. 30.– P. 1656–1664.

Human adipocytes secrete mineralocorticoid-releasing factors/ Ehrhart-Bornstein M., Lamounier-Zepter V., Schraven A. et al. // Proc. Natl. Acad. Sci. USA. – 2003. – V.100. – P. 14211–14216.

Weight loss and the renin-angiotensinaldosterone system/ Engeli S., Bohnke J., Gorzelniak K. et al.// Hypertens. – 2005. – V. 45. – P. 356–362.

Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion / Gaddam K.K., Nishizaka M.K., Pratt-Ubunama M.N. et al. // Arch. Intern. Med.– 2008.– Vol. 168.– P. 1159–1164.

Belovol A. N. Patofiziologicheskie mehanizmi razvitiya arterialnoi gipertenzii na fone ojireniya /A. N. Belovol_ V. V. Shkolnik // Naukovii jurnal MOZ Ukraїni.-2012.-№1.-S.142-153.

Human adipocytes secrete mineralocorticoid-releasing factors/ Ehrhart-Bornstein M., Lamounier-Zepter V., Schraven A. et al. // Proc. Natl. Acad. Sci. USA.– 2003.– Vol. 100.– P. 14211–14216.

Polyanskaya A. V. Diagnostika i lechenie rezistentnoi arterialnoi gipertenzii / Polyanskaya A. V. // Medicinskii jurnal. ‒ 2015. ‒ № 2. - S. 28-34.

Schastlivceva E.O. Geneticheskie aspekti individualizacii terapii beta_adrenoblokatorami /E.O.Schastlivceva //Kremlevskaya medicina: Klinicheskii vestnik.-2010.-№ 3.-S.79-83.

Nonnarcotic analgesic use and the risk of hypertension in US women/D J.edier, M.J.Stampfer, S.E.Hankinson et al. // Hypertension. – 2002. – V. 40. – P. 604–608.

Non-narcotic analgesic dose and risk of incident hypertension in US women/ J.P.For man, M.J.Stampfer, G.C.Curhan // Hypertens. – 2005. – V. 46. – P. 500–507.

Modafinil elicits sympatho-medullary activation/ I.Taneja, A. Diedrich, B.K.Black et al. // Hypertens. – 2005. – V. 45. –P. 612 – 618.

Dononsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis/ A.G.Johnson, T.V.Nguyen, R.O.Day // Ann. Intern. Med. – 1994. – V. 121. – P. 289 –300.

Joint statement of the European Association for the study of obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension./ Jordan J., Yumuk V., Schlaich M. et al.// J Hypertens.- 2012.-№30.-С. 1047-55.

Cibulkin N.A. Rezistentnaya gipertoniya_ ot sindroma k diagnozu/ N.A. Cibulkin// Prakticheskaya medicina.-2013.-№37.-C.7-11.

Blokada aldosterona — novaya strategiya lecheniya rezistentnoi arterialnoi gipertenzii /E.I. Baranova_ O.O. Bolshakova_ O.A. Berkovich//Arterialnaya gipertenziya.- 2008.-Tom 14, № 3.-S.203-210.




DOI: http://dx.doi.org/10.5281/zenodo.225448

Refbacks

  • There are currently no refbacks.




Copyright (c) 2016 © The Author (s) 2016

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Journal of Education, Health and Sport formerly Journal of Health Sciences

Declaration on the original version.

Editors indicates that the main version of the magazine is to issue a "electronic".

The journal has had 5 points in Ministry of Science and Higher Education parametric evaluation. § 8. 2) and § 12. 1. 2) 22.02.2019.

1223 Journal of Education, Health and Sport eISSN 2391-8306 7

ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

Archives 2011 - 2014

PBN 2011 - 2014

https://pbn.nauka.gov.pl/sedno-webapp/search?search&searchCategory=WORK&filter.inJournal=36616

POL-index 2011 - 2014

https://pbn.nauka.gov.pl/polindex-webapp/browse/journal/journal-32a319c5-a850-4f44-ba70-1418a6087655

BASE 2011 - 2014

https://www.base-search.net/Search/Results?lookfor=Journal+of+Health+Sciences+%28Radom%29&type=all&oaboost=1&ling=1&name=&thes=&refid=dcrespl&newsearch=1

http://elibrary.ru/contents.asp?titleid=37467

http://journal.rsw.edu.pl/index.php/JHS/issue/archive

Indexed in Bases, Bazy indeksacyjne: ERIH Plus, Worldcat, PBN/POL-Index, ICI Journals Master List, Directory of Open Access Journals (DOAJ), ZBD, Ulrich's periodicals, Google Scholar, Polska Bibliografia Lekarska

US NLM = 101679844

101679844 - NLM Catalog Result - NCBI

https://www.ncbi.nlm.nih.gov/nlmcatalog/101679844

Find a library that holds this journal: http://worldcat.org/issn/23918306

Journal Language(s): English 

PBN Poland

https://pbn.nauka.gov.pl/sedno-webapp/journals/49068

POL-index

https://pbn.nauka.gov.pl/polindex-webapp/browse/journal/journal-c39c8169-88d2-45db-9e7f-d948ce9981c4

BASE

https://www.base-search.net/Search/Results?join=AND&bool0[]=AND&lookfor0[]=2391-8306&type0[]=all&page=11&l=pl&oaboost=1&refid=dcpagepl

Redaction, Publisher and Editorial Office

Instytut Kultury Fizycznej Uniwersytet Kazimierza Wielkiego w Bydgoszczy, Institute of Physical Education Kazimierz Wielki University in Bydgoszcz, Poland 85-091 Bydgoszcz ul. Sportowa 2  www.ukw.edu.pl Copyright by Instytut Kultury Fizycznej UKW w Bydgoszczy http://ojs.ukw.edu.pl/index.php/johs  Open Access ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

The journal has been approved for inclusion in ERIH PLUS.

The ERIH PLUS listing of the journal is available at https://dbh.nsd.uib.no/publiseringskanaler/erihplus/periodical/info?id=485984

SIC Science citation index (calculated on the basis of TCI and Page Rank) 0

Russian Impact factor 0.16

Indexed in Index Copernicus Journals Master List.

http://journals.indexcopernicus.com/Journal+of+Education+Health+and+Sport,p24782242,3.html

ICV 2018 = 95.95 ICV 2017 = 91.30 ICV 2016 = 84.69 ICV 2015 = 93.34 ICV 2014 = 89.51 Standardized Value: 8.27 ICV 2013: 7.32 ICV 2012: 6.41 ICV 20115.48

The InfoBase Index IBI Factor for the year 2015 is 3.56 in InfoBase Index.com.

Website: www.infobaseindex.com

Universal Impact Factor 1.78 for year 2012. (http://www.uifactor.org/AppliedJournals.aspx)

Indexed in Polish Scholarly Bibliography (PBN) (PBN Polska Bibliografia Naukowa) (https://pbn.nauka.gov.pl/journals/36616)

is a portal of the Polish Ministry of Science and Higher Education, collecting information on publications of Polish scientists and on Polish and foreign scholarly journals. Polish Scholarly Bibliograhpy is a part of POL-on - System of Information on Higher Education. It is operated by the Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw.

Indexed in Russian Sciences Index Российский индекс научного цитирования (РИНЦ) http://elibrary.ru/contents.asp?titleid=37467

Indexed in Arianta Polish scientific and professional electronic journals Aneta Drabek i Arkadiusz Pulikowski

(http://www1.bg.us.edu.pl/bazy/czasopisma/czasop_full.asp?id=3595)